PDE III/IV inhibitors (Fujisawa/Klinge)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDE III/IV inhibitors (Fujisawa/Klinge)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitors
TargetsPhosphodiesterase 3Phosphodieterase 4
Therapy Area/IndicationsPainMigraine DisordersCough +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujisawa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKlinge Pharma GmbhFujisawa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPainMigraine DisordersCough +[4] 

Other Information

ATC CodeN/A
Related LinksN/A